Polyethylene glycol-based homologated ligands for nicotinic acetylcholine receptors

Bioorganic and Medicinal Chemistry

Volumn 16, Issue 24, 2008, Pages 10295-10300

  Scates, Bradley A ^a   Lashbrook, Bethany L ^a   Chastain, Benjamin C ^a   Tominaga, Kaoru ^a   Elliott, Brandon T ^a   Theising, Nicholas J ^a   Baker, Thomas A ^a   Fitch, Richard W ^a  

^a INDIANA STATE UNIVERSITY   (United States)

Author keywords

A 84543; ADMP; DMPP; Pyridyl ethers; SAR

Indexed keywords

A 84543; CHOLINE DERIVATIVE; MACROGOL DERIVATIVE; NICOTINIC RECEPTOR; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; DRUG CONJUGATION; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; LIGAND BINDING; NONHUMAN; RAT;

ANIMALS; CELL LINE; CEREBRAL CORTEX; LIGANDS; POLYETHYLENE GLYCOLS; PYRIDINES; RADIOLIGAND ASSAY; RATS; RECEPTORS, NICOTINIC; STRUCTURE-ACTIVITY RELATIONSHIP;

RATTUS;

EID: 56349165633     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2008.10.045     Document Type: Article

References (50)

1. Nicotinic see: Brown, J. H.; Taylor, P. In Goodman and Gilman's Pharmacological Basis of Therapeutics, 10th ed.; Hardman, J. G.; Limbird, L. E., Eds., New York: McGraw-Hill, Chapter 9, pp. 193-213.
2. Muscarinic, see: Brown, J. H.; Taylor, P. In Goodman and Gilman's Pharmacological Basis of Therapeutics, 10th ed.; Hardman, J. G.; Limbird, L. E., Eds., New York: McGraw-Hill, Chapter, Chapter 7 pp. 154-173.
3. Arneric S.P., Holladay M., and Williams M. Biochem. Pharmacol. 74 (2007) 1092
4. Gundisch D. Expert Opin. Ther. Pat. 15 (2005) 1221
5. Nicotinic receptors and pain. Bunnelle W.H., and Decker M.W. Exp. Opin. Therap. Pat 13 (2003) 1003-1021
6. Vincler. Expert Opin. Investig. Drugs 14 (2005) 1191
7. Tapper A.R., McKinney S.L., Nashmi R., Schwarz J., Desphande P., Labarca C., Whiteaker P., Marks M.J., Collins A.C., and Lester H.A. Science 306 (2004) 1029
8. Voineskos S., De Luca V., Mensah A., Vincent J.B., Potapova N., and Kennedy J.L. J. Psychiatry Neurosci. 32 (2007) 412
9. DeLeon J., Dadvand M., Canuso C., White A.O., Stanilla J.K., and Simpson G.M. Am. J. Psychiatry 152 (1995) 453
10. Spande T.F., Garraffo H.M., Edwards M.W., Yeh H.J.C., Pannell L., and Daly J.W. J. Am. Chem. Soc. 114 (1992) 3475
11. Lin, N. H.; He, Y.; Holladay, M. W.; Ryther, K.; Li, Y. 3-Pyridyloxymethyl Heterocyclic Ether Compounds Useful in Controlling Chemical Synaptic Transmission. Patent US 5,629,325, 1997.
12. Lin N.-H., Li Y., He Y., Holladay M.W., Kuntzweiler T., Anderson D.J., Campbell J.E., and Arneric S.P. Bioorg. Med. Chem. Lett. 11 (2001) 631
13. Gonzales D., Rennard S.I., Nides M., Oncken C., Azoulay S., Billing C.B., Watsky E.J., Gong J., Williams K.E., and Reeves K.R. J. Am. Med. Assoc. 296 (2006) 47
14. Jorenby D.E., Hays J.T., Rigotti N.A., Azoulay S., Watsky E.J., Williams K.E., Billing C.B., Gong J., and Reeves K.R. J. Am. Med. Assoc. 296 (2006) 56
15. Moaddel R., Oliveira R.V., Kimura T., Hyppolite P., Juhaszova M., Xiao Y., Kellar K.J., Bernier M., and Wainer I.W. Anal. Chem. 80 (2008) 48
16. Mammen M., Choi S.K., and Whitesides G.M. Angew. Chem. Int. Ed. Engl. 37 (1998) 2755
17. Gordon E.J., Gestwicki J.E., Strong L.E., Kiessling L.L., Gordon E.J., Gestwicki J.E., Strong L.E., and Kiessling L.L. Chem. Biol. 1 (2000) 9
18. Fan E., Zhang Z., Minke W.E., Hou Z., Verlinde C.L.M.J., and Hol W.G.J. J. Am. Chem. Soc. 122 (2000) 2663
19. Haag R., and Kratz F. Angew. Chem. Int. Ed. 45 (2006) 1198-1215
20. Bentley, M.D.; Bossard, M.J.; Burton, K.W.; Viegas, Tacey X. Poly(ethylene) Glycol Conjugates of Biopharmaceuticals, In Drug Delivery in Modern Biopharmaceuticals. Berlin: Wiley-VCH, 2005; Vol. 4, pp. 1193-1418.
21. Barlow R.B., Bremner J.B., and Soh K.S. Br. J. Pharmacol. 62 (1978) 39
22. Price C.C., Kabas G., and Nataka I. J. Med. Chem. 8 (1965) 650
23. Spivak C.E., Gund T.M., Liang R.F., and Waters J.A. Eur. J. Pharmacol. 120 (1986) 127
24. Manetti D., Bartolini A., Borea P.A., Bellucci C., Dei S., Ghelardini C., Gualtieri C., Romanelli M.N., Scapecci S., Teodori E., and Variani K. Bioorg. Med. Chem. 7 (1999) 457
25. Wei Z.L., Xiao Y., Yuan H., Baydyuk M., Petukhov P.A., Musachio J.L., Kellar K.J., and Kozikowski A.P. J. Med. Chem. 48 (2005) 1720
26. Kozikowski A.P., Chellappan S.K., Henderson D., Fulton R., Giboureau N., Xiao Y., Wei Z.L., Guilloteau D., Emond P., Dolle F., Kellar K.J., and Kassiou M. ChemMedChem 2 (2007) 54
27. For consistency the letter system for each series is such that a-g represent 0-6 ethylene oxide units. Thus, compound 4a is simply methanol and mesylate 5a does not appear.
28. Bertozzi C.R., and Bednarski M.D. J. Org. Chem. 56 (1991) 4326
29. Reddy V.V.S., Whitten J.E., Redmill K.A., Varshney A., and Gray G.M. J. Organomet. Chem. 372 (1989) 207
30. Schmidt M., Amstutz R., Crass G., and Seebach D. Chem. Ber. 113 (1980) 1691
31. Hurd C.D., and Fowler G.W. J. Am. Chem. Soc. 61 (1939) 249
32. Sokolowski A., Burczyk B., Acetals, et al. Pol. J. Chem. 53 (1979) 905
33. Matter, M.; Rossi, A.; von Sprecher, H. Polyglycol Ether Acid Anilides. US Patent 2,769,838, 1956.
34. Belaby, R.; Hazard, R.; Cheymol, J.; Chabrier, P.; Najer, H. "Diuréthans et Leur Préparation" Fr. 1,173,901, 1959, Chem. Abstr. 1962, 56, 1354f.
35. Jorand-Lebrun C., Valognes D., and Halazy S. Synth. Commun. 28 (1998) 1189
36. Sharma S., Agarwas V.K., Dubey S.K., Iyer R.N., Anand N., Chatterjee R.K., Chandra S., and Sen A.B. Ind. J. Chem. B. 26B (1987) 748
37. This is a fairly standard method for quaternization of amines and worked well for the preparation of ADMP, AaCh and lower mPEG oligomers (n = 0-2), affording crystalline compounds. However, crystallization of the higher oligomers proved more difficult and in many cases, we were unable to obtain precipitates from acetone or acetonitrile and addition of ether or hydrocarbon solvents produced only oils. While we do not have an explanation for this, the compounds gave satisfactory HRMS and NMR data (see Section 4).
38. Cosford N.D.P., Bleicher L., Herbaut A., McCallum J.S., Vernier J.-M., Dawson H., Whitten J.P., Adams P., Chavez-Noriega L., Correa L.D., Crona J.H., Mahaffy L.S., Menzaghi F., Rao T.S., Reid R., Sacaan A.I., Santori E., Stauderman K.A., Whelan K., Lloyd G.K., and McDonald I.A. J. Med. Chem. 39 (1996) 3235
39. De Halleux V., Mamdouh W., De Feyter S., De Schryver F., Levin J., and Geerts Y.H. J. Photochem. Photobiol. A 178 (2006) 251
40. Li Q.X., and Casida J.E. Bioorg. Med. Chem. 3 (1995) 1667
41. An excess of the alkyne is required as the alkynylpyridine product is virtually inseparable from the starting bromopyridine and thus the reaction must be forced to completion.
42. Houghtling R.A., Davila-Garcia M.I., and Kellar K.J. Mol. Pharmacol. 48 (1995) 280
43. Miyazawa A., Fujiyoshi Y., Stowell M., and Unwin N. J. Mol. Biol 288 (1999) 765
44. Unwin N. J. Mol. Biol. 346 (2005) 967
45. Smit A.B., Syed N.I., Schapp D., van Minnen J., Klumperman J., Kits K.S., Lodder H., van der Schors R.C., van Elk R., Sorgedrager B., Brejc K., Sixma T.K., and Geraerts W.P.M. Nature 411 (2001) 261
46. Brejc K., van Dijk W.J., Klassen R.V., Schuurmans M., van der Oost J., Smit A.B., and Sixma T.K. Nature 411 (2001) 269
47. Veliçelebi G., Stauderman K.A., Varney M.A., Akong M., Hess S.D., and Johnson E.C. Meth. Enzymol. 279 (1999) 20
48. Fitch R.W., Pei X.F., Kaneko Y., Gupta T., Shi D., Federova I., and Daly J.W. Bioorg. Med. Chem. Lett. 12 (2004) 179
49. Xiao Y., and Kellar K.J. J. Pharmacol. Exp. Ther. 310 (2004) 98
50. Xiao Y.l., Meyer E.L., Thompson J.M., Surin A., Wroblewski J., and Kellar K.J. Mol. Pharmacol. 54 (1996) 322